Introduction :

Dolphin Pharmaceuticals is a leading Darbepoetin alfa supplier from India, based in Surat, Gujarat, specializing in the global supply of high-quality specialty medicines. We serve pharmacy, distributors, hospitals, and healthcare organizations worldwide with quality-assured Darbepoetin alfa

Darbepoetin alfa is primarily used to treat anemia associated with chronic kidney disease and, in selected patients, anemia caused by chemotherapy under the supervision of qualified healthcare professionals. Dolphin Pharmaceuticals is committed to providing authentic medicines, competitive pricing, complete support, global healthcare requirements.

Kabidabra 40 Injection:

Kabidabra (Darbepoetin alfa) is a prescription medicine used to treat anemia associated with chronic kidney disease and, in selected patients, anemia caused by chemotherapy. It belongs to the class of erythropoiesis-stimulating agents (ESAs). The product is stated to be manufactured and marketed by Fresenius Kabi Oncology Ltd. Darbepoetin alfa acts similarly to the natural hormone erythropoietin by stimulating the bone marrow to produce more red blood cells, thereby increasing hemoglobin levels and improving oxygen delivery throughout the body. It may help reduce anemia-related symptoms, such as fatigue and weakness, and reduce the need for red blood cell transfusions in eligible patients. The medicine is administered by injection under appropriate medical supervision, with regular monitoring of hemoglobin levels and blood pressure because of the risk of hypertension and cardiovascular complications.

Product Introduction

Darbepoetin alfa Injection is a prescription medicine used to treat anemia associated with chronic kidney disease and certain cases of chemotherapy-induced anemia. It contains darbepoetin alfa, an erythropoiesis-stimulating agent (ESA) that helps the bone marrow produce more red blood cells, thereby increasing hemoglobin levels and improving oxygen delivery throughout the body. This medicine is administered by a qualified healthcare professional according to the dose and schedule prescribed by the doctor. Regular blood tests are necessary to monitor hemoglobin levels, blood pressure, and other relevant parameters during treatment.

Common side effects may include high blood pressure, skin rash, injection-site pain, and, in some cases, seizures. Darbepoetin alfa Injection should be used cautiously in patients with cardiovascular disease, uncontrolled hypertension, or a history of stroke or seizures. Inform your doctor if you are pregnant, breastfeeding, or taking other medicines. Seek immediate medical attention if you experience severe headaches, vision changes, seizures, chest pain, or difficulty breathing.

Uses of Darbepoetin alfa Injection

• Treatment of anemia associated with chronic kidney disease.

• Treatment of anemia caused by chemotherapy in eligible cancer patients.

Benefits of Darbepoetin alfa Injection

Treatment of Anemia Due to Cancer Chemotherapy

Chemotherapy can reduce red blood cell production, resulting in anemia, fatigue, weakness, and reduced physical stamina. Darbepoetin alfa Injection stimulates the bone marrow to produce more red blood cells, helping increase hemoglobin levels and reduce the need for red blood cell transfusions in some eligible patients. Its use depends on the type of cancer, chemotherapy regimen, and individual risk factors.

Treatment of Anemia Due to Chronic Kidney Disease

Chronic kidney disease can reduce the production of erythropoietin, a hormone needed for red blood cell formation. This may lead to anemia, causing tiredness, weakness, and reduced exercise tolerance. Darbepoetin alfa Injection helps stimulate red blood cell production, improve hemoglobin levels, and relieve anemia-related symptoms in appropriate patients.

Side Effects of Darbepoetin alfa Injection

Some side effects may be mild, while others require prompt medical attention. Consult your doctor if any symptoms persist or worsen.

Common or important side effects include:

• High blood pressure

• Skin rash

• Injection-site pain

• Seizures or convulsions

Other possible concerns include blood clots and cardiovascular complications, particularly when hemoglobin rises excessively or blood pressure is not adequately controlled.

Seek urgent medical attention if you experience severe headache, sudden vision changes, chest pain, difficulty breathing, weakness on one side of the body, or seizures.

How Darbepoetin alfa Injection Works

Kabidabra 40 Injection contains darbepoetin alfa, a synthetic form of a hormone that stimulates red blood cell production. It acts on erythropoietin receptors in the bone marrow, promoting the development and maturation of red blood cells. As red blood cell production increases, hemoglobin levels may improve, allowing the blood to carry oxygen more effectively to tissues throughout the body.